Recent developments include Clorox surpassing Q1 fiscal 2027 earnings and revenue expectations, announcing a new CEO appointment effective January 2027, and facing macroeconomic headwinds impacting business performance.

• Clorox reported Q1 fiscal 2027 earnings and revenues surpassing expectations, reflecting operational improvements and cost management [N1].
• The company scheduled its Q1 2027 earnings conference call for November 2, 2026, providing further insights into financial performance [N2].
• Key insights for investors ahead of Q1 earnings highlighted ongoing strategic initiatives and market conditions [N3].
• Fabian Garcia was appointed as CEO effective January 5, 2027, succeeding Linda Rendle, signaling leadership transition [N5][N6].
• Macroeconomic headwinds continue to impact Clorox from multiple fronts, influencing sales and operational dynamics [N8].

Clorox's broad and diversified brand portfolio with leading market shares provides resilience and growth opportunities. The IGNITE strategy's focus on innovation, digital transformation, and sustainability aligns with evolving consumer preferences and operational efficiencies. The GOJO acquisition expands the company's footprint in health and hygiene, particularly in B2B channels, potentially driving recurring demand. The company's commitment to dividends and strong brand equity supports shareholder value and market confidence.

Macroeconomic uncertainties and consumer behavior shifts have led to organic sales and earnings declines, highlighting sensitivity to external factors. The ERP system implementation caused near-term disruptions and sales timing impacts. Clorox faces intense competition from both national and private label brands, as well as retailers, which could pressure pricing and market share. Exposure to commodity price volatility and supply chain risks may affect costs and margins. The company's current liquidity ratios indicate potential short-term liquidity constraints, with a current ratio below 1.0.

Clorox's moat is anchored in its portfolio of trusted, market-leading brands with strong consumer recognition and loyalty. Over 80% of sales come from brands ranked No. 1 or No. 2 in their categories. The company's extensive distribution network across retail and professional channels, combined with its innovation capabilities and integrated sustainability strategy, supports competitive differentiation. The recent acquisition of GOJO enhances its presence in professional hygiene markets, further strengthening its competitive position. Brand protection through trademarks and patents also contributes to its moat.

• Macroeconomic and Consumer Behavior Risks: Ongoing macroeconomic uncertainty influences consumer shopping behaviors, resulting in category slowdowns and lower sales.
• ERP System Implementation Risks: The recent ERP system implementation caused near-term disruptions and sales timing impacts that affected fiscal 2026 results.
• Competitive Risks: Clorox faces intense competition from national brands, private labels, and retailers, which could reduce net sales and earnings.
• Supply Chain and Commodity Price Risks: The company is exposed to volatility in raw material prices, transportation costs, and potential supply disruptions.
• Liquidity Risks: As of September 30, 2026, the current ratio was 0.65, indicating current liabilities exceed current assets, which may pose short-term liquidity challenges.

• The Clorox Company is a multinational manufacturer and marketer of consumer and professional products with fiscal year 2026 net sales of $6.7 billion and about 9,200 employees worldwide as of June 30, 2026.
• Clorox operates in approximately 25 countries and sells products in about 95 markets primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors.
• The company markets well-known brands including Clorox, Pine-Sol, Liquid-Plumr, Poett, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, Burt’s Bees, Purell, CloroxPro, and Clorox Healthcare.
• Over 80% of sales come from brands holding No. 1 or No. 2 market share positions in their categories.
• In April 2026, Clorox acquired GOJO, adding the Purell brand and health and hygiene solutions, expanding its B2B presence especially in healthcare and institutional markets.
• Clorox’s IGNITE strategy focuses on innovation, consumer experience, operational transformation, and sustainability to drive long-term profitable growth.
• Fiscal year 2026 saw decreases in organic sales and earnings due to macroeconomic uncertainty, ERP system implementation timing, and higher manufacturing and logistics costs.
• The company completed its ERP system implementation in Q3 fiscal 2026, with a total incremental transformational investment of approximately $580 million.
• Clorox simplified its operating structure in fiscal 2026 to streamline leadership and align resources for growth and portfolio optimization.
• The company prioritizes sustainability goals embedded in its IGNITE strategy, focusing on greenhouse gas emission reductions and waste reduction.
• Clorox paid $602 million in dividends in fiscal 2026 and announced a 1% dividend increase in July 2026.
• The company operates four reportable segments: Health and Wellness, Household, Lifestyle, and International, covering cleaning, disinfecting, bags and wraps, cat litter, grilling products, food, water-filtration, and personal care products.
• Major customers include Walmart, accounting for about 26% of consolidated net sales in fiscal 2026, with the top five customers accounting for about half of sales.
• Raw materials include resins, non-woven fabrics, sodium hypochlorite, corrugated cardboard, soybean oil, solvents, amines, and agricultural commodities; supply risks exist but were minimal in fiscal 2026.
• Clorox uses derivative instruments and long-term contracts to mitigate raw material price volatility but remains exposed to commodity and transportation cost changes.
• The company invests in research and development focused on product formulation, packaging innovation, manufacturing efficiency, dispensing systems, and digital tools.
• As of September 30, 2026, Clorox had $184 million in cash and cash equivalents, current assets of $1.931 billion, current liabilities of $2.954 billion, a current ratio of 0.65, and a cash ratio of 0.06.
• For the quarter ended September 30, 2026, net sales were $1.905 billion, net earnings attributable to Clorox were $170 million, and diluted EPS was $1.39.
• Recent news highlights include Clorox surpassing Q1 earnings and revenue estimates for fiscal 2027, appointment of Fabian Garcia as CEO effective January 5, 2027, and macroeconomic headwinds impacting the company.
• Clorox continues to launch new products and innovations across its portfolio, including Clorox PURE, Clorox Screen+ Sanitizing Wipes, and expanded professional hygiene solutions.
• The company faces intense competition from national brands, private labels, retailers, and competitors in B2B channels, competing on product performance, brand reputation, innovation, and marketing effectiveness.